Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Aug-21 5:13 PM View:  | Nabriva Therapeutics Plc (NBRV) | 06-Aug-21 | Payment of Exercise | 74 | $1.17 | $86.58 | (< 1%) 41.3K to 41.23K | 3% |
| 02-Jul-21 10:00 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Jun-21 | Payment of Exercise | 37 | $1.35 | $49.95 | (< 1%) 41.45K to 41.42K | 4% |
| 08-Jun-21 4:05 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Jun-21 | Payment of Exercise | 73 | $1.34 | $97.82 | (< 1%) 41.53K to 41.45K | (5%) |
| 02-Jun-21 4:11 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-21 | Payment of Exercise | 37 | $1.38 | $51.06 | (< 1%) 41.56K to 41.53K | (< 1%) |
| 10-May-21 5:51 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-May-21 | Payment of Exercise | 74 | $1.49 | $110.26 | (< 1%) 41.64K to 41.56K | 1% |
| 04-May-21 4:04 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-21 | Payment of Exercise | 37 | $1.78 | $65.86 | (< 1%) 41.67K to 41.64K | 3% |
| 08-Apr-21 9:46 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Apr-21 | Payment of Exercise | 74 | $1.73 | $128.02 | (< 1%) 41.75K to 41.67K | 3% |
| 02-Apr-21 6:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-21 | Payment of Exercise | 37 | $1.66 | $61.42 | (< 1%) 42.73K to 42.69K | (5%) |
| 08-Apr-21 9:46 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Mar-21 | Payment of Exercise | 71 | $1.79 | $127.09 | (< 1%) 41.82K to 41.75K | 6% |
| 02-Mar-21 7:37 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-21 | Payment of Exercise | 38 | $2.39 | $90.82 | (< 1%) 42.76K to 42.73K | 20% |
| 08-Apr-21 9:46 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-21 | Payment of Exercise | 870 | $2.90 | $2,523.00 | (2%) 42.69K to 41.82K | 42% |
| 02-Feb-21 8:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-21 | Payment of Exercise | 43 | $2.62 | $112.66 | (< 1%) 42.81K to 42.76K | |
| 02-Feb-21 8:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 29-Jan-21 | Grant | 22,500 | -- | -- | 111% 20.31K to 42.81K | |
| 05-Jan-21 5:12 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Dec-20 | Payment of Exercise | 37 | $2.42 | $89.54 | (< 1%) 20.34K to 20.31K | (4%) |
| 01-Dec-20 8:20 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Nov-20 | Payment of Exercise | 368 | $0.43 | $157.14 | (< 1%) 203.81K to 203.44K | 38% |
| 02-Nov-20 7:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Oct-20 | Payment of Exercise | 366 | $0.50 | $181.35 | (< 1%) 204.18K to 203.81K | 46% |
| 01-Oct-20 4:30 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Sep-20 | Payment of Exercise | 366 | $0.53 | $195.08 | (< 1%) 204.54K to 204.18K | 50% |
| 02-Sep-20 5:14 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Aug-20 | Payment of Exercise | 366 | $0.62 | $226.70 | (< 1%) 204.91K to 204.54K | 57% |
| 21-Aug-20 7:03 PM View: | Nabriva Therapeutics Plc (NBRV) | 20-Aug-20 | Payment of Exercise | 3,759 | $0.65 | $2,434.33 | (2%) 208.67K to 204.91K | 59% |
| 21-Aug-20 7:03 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Aug-20 | Option Exercise | 11,250 | -- | -- | 6% 197.42K to 208.67K | |
| 04-Aug-20 4:57 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-20 | Payment of Exercise | 366 | $0.76 | $278.16 | (< 1%) 197.78K to 197.42K | 65% |
| 02-Jul-20 4:08 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Jun-20 | Payment of Exercise | 366 | $0.67 | $246.90 | (< 1%) 198.15K to 197.78K | 59% |
| 03-Jun-20 6:05 AM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-20 | Payment of Exercise | 366 | $1.14 | $417.24 | (< 1%) 198.52K to 198.15K | 76% |
| 04-May-20 6:33 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-20 | Payment of Exercise | 366 | $0.55 | $200.68 | (< 1%) 198.88K to 198.52K | 49% |
| 02-Apr-20 5:48 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-20 | Payment of Exercise | 366 | $0.57 | $210.45 | (< 1%) 199.25K to 198.88K | 53% |
| 03-Mar-20 9:31 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-20 | Payment of Exercise | 366 | $1.35 | $494.10 | (< 1%) 199.64K to 199.28K | 80% |
| 10-Feb-20 8:26 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-20 | Grant | 105,000 | -- | -- | 126% 83.1K to 188.1K | |
| 04-Feb-20 8:55 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-20 | Payment of Exercise | 3,892 | $1.35 | $5,254.20 | (2%) 173.98K to 170.09K | 80% |
| 21-Aug-19 9:22 PM View: | Nabriva Therapeutics Plc (NBRV) | 21-Aug-19 | Payment of Exercise | 3,797 | $2.08 | $7,897.76 | (14%) 27.04K to 23.24K | 87% |
| 21-Aug-19 9:22 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Aug-19 | Option Exercise | 11,250 | -- | -- | 71% 15.79K to 27.04K | |
| 23-May-18 12:29 PM View: | Nabriva Therapeutics Plc (NBRV) | 23-May-18 | Market Purchase | 10,000 | $4.48 | $44,800.00 | 100% 0 to 10.0K | (94%) |
| 18-Feb-15 8:23 PM View: | Dendreon Corp. (DNDN) | 17-Feb-15 | Sale | 21,764 | $0.08 | $1,765.06 | (18%) 119.62K to 97.86K | |
| 02-Feb-15 8:16 PM View: | Dendreon Corp. (DNDN) | 31-Jan-15 | Payment of Exercise | 470 | $0.16 | $75.20 | (< 1%) 120.09K to 119.62K | 19% |
| 02-Dec-14 7:39 PM View: | Dendreon Corp. (DNDN) | 30-Nov-14 | Payment of Exercise | 912 | $0.14 | $125.86 | (< 1%) 121.0K to 120.09K | |
| 03-Nov-14 5:19 PM View: | Dendreon Corp. (DNDN) | 31-Oct-14 | Payment of Exercise | 472 | $0.98 | $462.32 | (< 1%) 121.47K to 121.0K | 89% |
| 03-Sep-14 5:45 PM View: | Dendreon Corp. (DNDN) | 31-Aug-14 | Payment of Exercise | 912 | $1.36 | $1,240.32 | (< 1%) 122.39K to 121.47K | 92% |
| 04-Aug-14 7:30 PM View: | Dendreon Corp. (DNDN) | 31-Jul-14 | Payment of Exercise | 472 | $2.07 | $977.04 | (< 1%) 122.86K to 122.39K | 95% |
| 03-Jun-14 4:34 PM View: | Dendreon Corp. (DNDN) | 31-May-14 | Payment of Exercise | 912 | $2.16 | $1,969.92 | (< 1%) 123.77K to 122.86K | 95% |
| 01-May-14 4:48 PM View: | Dendreon Corp. (DNDN) | 30-Apr-14 | Payment of Exercise | 459 | $2.58 | $1,184.22 | (< 1%) 124.23K to 123.77K | 96% |
| 04-Mar-14 11:54 AM View: | Dendreon Corp. (DNDN) | 28-Feb-14 | Grant | 60,000 | -- | -- | 88% 68.18K to 128.18K | |
| 04-Mar-14 11:54 AM View: | Dendreon Corp. (DNDN) | 28-Feb-14 | Payment of Exercise | 3,955 | $2.88 | $11,390.40 | (3%) 128.18K to 124.23K | 96% |